Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 1018Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
BRIEF COMMUNICATION

Impact of COVID-19 on management of clinical trials and the potential mitigating strategies


1 IQVIA, Clinical Operations, IQVIA RDS India Pvt Ltd, Thane, Maharashtra, India
2 Department of Medical Research, Bhaktivedanta Hospital and Research Institute, Thane, Maharashtra, India
3 Department of Clinical Trial, Raptim Research, Navi Mumbai, Maharashtra, India
4 Clinical Operations, Novo Nordisk, Bengaluru, Karnataka, India
5 Medpace, Navi Mumbai, Maharashtra, India

Correspondence Address:
Vijaykumar Gawali,
Shrishti Complex, Bhaktivedanta Swami Marg, Sector 1, Mira Road (East), Thane - 401 107, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/picr.picr_25_22

    
 

  Search Pubmed for
 
    -  Sarve P
    -  Gawali V
    -  Ali H
    -  Tattu S
    -  Chetule C
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed289    
    PDF Downloaded4    

Recommend this journal